Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Pharmaxis Ltd ( (AU:SNT) ) has shared an update.
Syntara Limited has announced a new application for the quotation of securities on the Australian Securities Exchange (ASX). The company is set to quote 281,240 ordinary fully paid securities, with the issue date being June 16, 2025. This move indicates Syntara Limited’s strategic efforts to enhance its market presence and potentially attract more investors. The issuance of these securities could have implications for the company’s financial structure and stakeholder interests.
The most recent analyst rating on (AU:SNT) stock is a Buy with a A$0.25 price target. To see the full list of analyst forecasts on Pharmaxis Ltd stock, see the AU:SNT Stock Forecast page.
More about Pharmaxis Ltd
Average Trading Volume: 8,462,253
Technical Sentiment Signal: Buy
Current Market Cap: A$108.9M
For an in-depth examination of SNT stock, go to TipRanks’ Overview page.